Procalcitonin as a prognostic biomarker of severe sepsis and septic shock;Procalcitonina como biomarcador de prognóstico da sepse grave e choque séptico

Revista do Colegio Brasileiro de Cirurgioes

Volumn 39, Issue 6, 2012, Pages 456-460

  De Azevedo, José Raimundo Araujo ^a   Torres, Orlando Jorge Martins ^a   Czeczko, Nicolau Gregori ^b   Tuon, Francisco Felipe ^b   Nassif, Paulo Afonso Nunes ^b   De Souza, Gleim Dias ^c  

^a São Domingos Hospital   (Brazil)

^b Medical Research Institute   (Brazil)

^c University Evangelic Hospital/Evangelic Faculty of Parana   (Brazil)

Author keywords

Biological markers; Patients; Prognosis; Sepsis; Septic shock

Indexed keywords

EID: 84873199779     PISSN: 01006991     EISSN: 18094546     Source Type: Journal    
DOI: 10.1590/S0100-69912012000600003     Document Type: Article

References (26)

1. Sexton PM, Christopoulos G, Christopoulos A, Nylen ES, Snider RH Jr, Becker KL. Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis. Crit Care Med. 2008;36(5):1637-40.
2. Hoffmann G, Totzke G, Seibel M, Smolny M, Wiedermann FJ, Schobersberger W. In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin. Crit Care Med. 2001;29(1):112-6.
3. Macedo JLS, Rosa SC, Macedo KCS, Castro C. Fatores de risco da sepse em pacientes queimados. Rev Col Bras Cir. 2005;32(4):173-7.
4. Macri MM, Matias JEF, Souza CJF, Nicoluzzi JEL, Caron PE, Repka JCD. Influência do pneumoperitônio nas funções hepática e renal e na liberação de citocinas pró-inflamatórias em modelo experimental de endotoxemia induzida por lipopolissacarídeo de Escherichia coli. ABCD arq bras cir dig. 2009;22(4):206-11.
5. Lima JBA. Skare TL, Malafaia O, Ribas-Filho JM, Michaelis T, Ribas FM, et al. Síndrome de disfunção de múltiplos órgãos induzida por sepse: estudo experimental em ratos. ABCD arq bras cir dig. 2011;24(2): 95-102.
6. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7(3):210-7.
7. Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sahuquillo JM, et al. Sequential measurements of procalcitonin levels in diagnosis of ventilator-associated pneumonia. Eur Respir J. 2008;31(2):356-62.
8. Rau BM, Kemppainen EA, Gumbs AA, Büchler MW, Wegscheider K, Bassi C, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg. 2007;245(5):745-54.
9. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infection in primary care. Arch Intern Med. 2008;168(18):2000-7.
10. Meng FS, Su L, Tang YQ, Wen Q, Liu YS, Liu ZF. Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem. 2009;42(10-11):1025-31.
11. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006;34(10):2596-602.
12. Karlsson S, Heikkinen M, Pettilä V, Alila S, Väisänen S, Pulkki K, et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care. 2010;14(6):R205.
13. Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, Huyghens L, et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med. 2002;30(4):757-62.
14. Velho AV, Mello LF, Oliveira Filho T, Dacanal FM, Ostermann RAB. Fatores preditivos de infecção no trauma de cólon. Rev Col Bras Cir. 2000;27(3):155-61.
15. Rocha SL, Souza GRMR, Abujamra KB, Ostrowski MAB, Souza MCMR. Gasometria arterial e inflamação pulmonar de ratos com diferentes tempos de sepse abdominal. ABCD arq bras cir dig. 2007;20(1):28-33.
16. Guan J, Lin Z, Lue H. Dynamic change of procalcitonin, rather than concentration itself, is predictive of survival in septic shock patients when beyond 10ng/ml. Shock. 2011;36(6):570-4.
17. Ruiz-Rodríguez JC, Caballero J, Ruiz-Sanmartin A, Ribas VJ, Pérez M, Bóveda JL, et al. Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study. Med Intensiva. 2012;36(7):475-80.
18. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2008;34(1):17-60.
19. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study. JAMA. 1995;273(2):117-23.
20. Sprung CL, Sakr Y, Vincent JL, Le Gall JR, Reinhart K, Ranieri VM, et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Intensive Care Med. 2006;32(3):421-7.
21. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Chest. 1992;101(6):1644-55.
22. Azevedo JR, Araujo LO, da Silva WS, Azevedo RP. A carbohydrate- restrictive strategy is safer and as efficient as intensive insulin therapy in critically ill patients. J Crit Care. 2010;25(1):84-9.
23. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al. Drotrecogin alfa (activated) in adults with septic shock. Vangerow B, Williams MD; PROWESS-SHOCK Study Group. Drotecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055-64.
24. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-8.
25. Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009;37(5):1649-54.
26. Suberviola B, Castellanos-Ortega A, González-Castro A, García-Astudillo LA, Fernández-Miret B. Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock. Med Intensiva. 2012;36(3):177-184.